1-1 AN ACT
1-2 relating to the establishment of a pediatric diabetes research
1-3 advisory committee in the Texas Department of Health.
1-4 BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
1-5 SECTION 1. (a) The commissioner of public health, in
1-6 consultation with the Texas Diabetes Council, shall establish a
1-7 pediatric diabetes research advisory committee.
1-8 (b) The pediatric diabetes research advisory committee is
1-9 composed of the chairman of the Texas Diabetes Council or that
1-10 person's designee and not more than 14 additional members appointed
1-11 by the commissioner of public health in consultation with the Texas
1-12 Diabetes Council as follows:
1-13 (1) one or more representatives of the Texas
1-14 Department of Health;
1-15 (2) one or more representatives of the Juvenile
1-16 Diabetes Research Foundation;
1-17 (3) one or more representatives of the American
1-18 Diabetes Association;
1-19 (4) one or more research professionals from academic
1-20 or biomedical research institutions in this state currently
1-21 involved in diabetes research; and
1-22 (5) one or more representatives of the health care
1-23 industry.
1-24 (c) The commissioner of public health shall select members
1-25 of the pediatric diabetes research advisory committee based on the
2-1 members' experience, expertise, or special interest in diabetes
2-2 and:
2-3 (1) ophthalmology;
2-4 (2) pediatric endocrinology;
2-5 (3) child health and development;
2-6 (4) neuropathy;
2-7 (5) genetics;
2-8 (6) cardiology; or
2-9 (7) immunology.
2-10 (d) The commissioner of public health, with recommendations
2-11 from the Texas Diabetes Council, shall select a member of the
2-12 pediatric diabetes research advisory committee to serve as the
2-13 presiding officer of the committee. The presiding officer may not
2-14 be an officer or employee of the state.
2-15 (e) The pediatric diabetes research advisory committee
2-16 shall:
2-17 (1) develop a plan to research pediatric diabetes and
2-18 medical conditions associated with diabetes in this state;
2-19 (2) assess the resources and talent of institutions in
2-20 this state as possible sites for research opportunities;
2-21 (3) analyze the impact of diabetes on the economy of
2-22 this state and on the health of the residents of this state; and
2-23 (4) make recommendations to the legislature and
2-24 governor concerning research programs in pediatric diabetes and
2-25 funding alternatives for the programs.
2-26 (f) The pediatric diabetes research advisory committee shall
3-1 meet at least four times as determined by the presiding officer. A
3-2 professional facilitator with experience in strategic planning
3-3 shall facilitate meetings of the committee.
3-4 (g) A member of the pediatric diabetes research advisory
3-5 committee may not receive compensation for service on the committee
3-6 but is entitled to reimbursement for reasonable and necessary
3-7 travel expenses incurred by the member while conducting the
3-8 business of the committee as provided by general law and the
3-9 General Appropriations Act.
3-10 (h) Not later than December 1, 2002, the commissioner of
3-11 public health shall submit a report prepared by the pediatric
3-12 diabetes research advisory committee to the governor, lieutenant
3-13 governor, and speaker of the house of representatives regarding
3-14 pediatric diabetes that comprehensively addresses the issues listed
3-15 in Subsection (e) of this section.
3-16 SECTION 2. The commissioner of public health shall appoint
3-17 members to the pediatric diabetes research advisory committee not
3-18 later than the 90th day after the effective date of this Act.
3-19 SECTION 3. The pediatric diabetes research advisory
3-20 committee is abolished January 1, 2003.
3-21 SECTION 4. This Act expires September 1, 2003.
3-22 SECTION 5. This Act takes effect immediately if it receives
3-23 a vote of two-thirds of all the members elected to each house, as
3-24 provided by Section 39, Article III, Texas Constitution. If this
3-25 Act does not receive the vote necessary for immediate effect, this
3-26 Act takes effect September 1, 2001.
_______________________________ _______________________________
President of the Senate Speaker of the House
I hereby certify that S.B. No. 1456 passed the Senate on
April 5, 2001, by the following vote: Yeas 30, Nays 0, one
present, not voting.
_______________________________
Secretary of the Senate
I hereby certify that S.B. No. 1456 passed the House on
May 8, 2001, by the following vote: Yeas 147, Nays 0, two present,
not voting.
_______________________________
Chief Clerk of the House
Approved:
_______________________________
Date
_______________________________
Governor